Rune Skeie
Director Financiero/CFO en BERGENBIO ASA .
Origen de la red de primer grado Rune Skeie.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 32 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Rune Skeie a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| University of Bergen | College/University | Corporate Officer/Principal Undergraduate Degree Corporate Officer/Principal Doctorate Degree | |
| University of Oxford | College/University | Doctorate Degree Graduate Degree Doctorate Degree | |
Piramed Ltd.
 Piramed Ltd. Miscellaneous Commercial ServicesCommercial Services PIramed Ltd. develops drugs, diagnostics, and other therapeutic products. It develops treatment for cancers which include proliferation, invasion, angiogenesis, and metastasis. The company was co-founded by Michael Waterfield, Peter Parker, and Paul Workman in 2003 and is headquartered in Slough, UK. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
Investinor AS
 Investinor AS Investment ManagersFinance Investinor AS is a Venture Capital firm, a subsidiary of Innovasjon Norge founded in 2008. The company is headquartered in Trondheim. | Investment Managers | Chairman Private Equity Investor | |
Pluvia AS
 Pluvia AS Miscellaneous Commercial ServicesCommercial Services Pluvia AS operates as a research-based pharmaceutical company. The company is headquartered in Bergen, Norway. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
Papyrus Therapeutics, Inc.
 Papyrus Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Papyrus Therapeutics, Inc. is a preclinical stage biopharma American company that focuses on developing cancer therapeutics based on a novel target, opioid-binding cell adhesion molecule (OPCML). Papyrus Therapeutics is based in Oxford, UK. The company's expertise in this target is based on years of research and multiple publications by the company's co-founder and chief scientific adviser, Professor Hani Gabra. The company was founded by Paul Blake and Hani Gabra, and Paul Blake has been the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member Founder | |
Helse Bergen HF Haukeland Universitetssjukehus
 Helse Bergen HF Haukeland Universitetssjukehus Medical/Nursing ServicesHealth Services Helse Bergen HF Haukeland Universitetssjukehus is a healthcare company based in Bergen, Norway. Haukeland universitetssjukehus has over 14,000 skilled employees who work every day to provide patients with high-quality specialist health services when they need them. The Norwegian company is ultimately controlled by the Government of Norway. The company was founded in 2001, and the CEO is Eivind Hansen. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Norwegian School of Economics & Business Administration | College/University | Undergraduate Degree Graduate Degree | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Oxford Brookes University | College/University | Masters Business Admin Graduate Degree | |
| THERACRYF PLC | Medical/Nursing Services | Chairman Director/Board Member | |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer | |
| Bergen Hospital Trust | Director/Board Member Chief Executive Officer | ||
| University of Oslo | College/University | Graduate Degree Graduate Degree | |
Lifearc
 Lifearc Miscellaneous Commercial ServicesCommercial Services Lifearc provides research services. It specializes in intellectual property management, drug discovery, medical diagnostics and antibody engineering. The firm services include complete technology transfer service for scientists in MRC units and institutes, Awards to Inventors, Collaborative drug discovery and antibody engineering, Funding early stage research with commercial/translational potential and protecting new ideas. The company is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Chief Operating Officer | |
Cancer Research Technology Ltd.
 Cancer Research Technology Ltd. Medical SpecialtiesHealth Technology Cancer Research Technology Ltd. develops cancer therapeutics, vaccines, and diagnostics. The firm also provides project development, commercialization, drug discovery, clinical development, imaging, and funding services. The company was founded in 2002 and is headquartered in London, the United Kingdom. | Medical Specialties | Chief Executive Officer Corporate Officer/Principal | |
| King's College London | College/University | Graduate Degree Graduate Degree | |
Sarsia Venture Management AS
 Sarsia Venture Management AS Investment ManagersFinance Sarsia Venture Management AS (SVM) is a venture capital advisory and management firm based in Bergen, Norway. They manage and advise the Sarsia Life Science Fund, established in 2005, which focuses on life science and biotechnology opportunities in the Nordic region. | Investment Managers | Private Equity Investor | |
| VERNALIS | Pharmaceuticals: Major | Corporate Officer/Principal | |
DCC Healthcare Ltd.
 DCC Healthcare Ltd. Medical DistributorsDistribution Services DCC Healthcare Ltd. supplies medical, surgical, and laboratory equipment and pharmaceuticals to the Irish healthcare sector. The company is headquartered in Stillorgan, Ireland. | Medical Distributors | Chief Executive Officer | |
| RECKITT BENCKISER GROUP PLC | Household/Personal Care | Sales & Marketing | |
| University of Bath | College/University | Masters Business Admin | |
Aenova Holding GmbH
 Aenova Holding GmbH Medical DistributorsDistribution Services Aenova Holding GmbH provides supplies to the pharmaceutical and healthcare industries. The firm develops, produces, and markets solid dosage products such as soft and hard capsules, tablets, film-coated tablets, and effervescent tablets. Its services include production, supply chain management, packaging, support and analytics. The company was founded in 2008 and is headquartered in Starnberg, Germany. | Medical Distributors | Chief Executive Officer | |
Eli Lilly Norge AS
 Eli Lilly Norge AS Medical DistributorsDistribution Services Eli Lilly Norge AS engages in the provision of pharmaceutical products and services. Its commodities were developed for the treatment of diabetes, cardiovascular diseases, cancer, nervous system, osteoporosis, psoriasis, rheumatology, urology, and growth failure. The company was founded in 1976 and is headquartered in Oslo, Norway. | Medical Distributors | Corporate Officer/Principal | |
Catalent Pharma Solutions Ltd.
 Catalent Pharma Solutions Ltd. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions Ltd. develops and markets drug delivery systems. The company is headquartered in Swindon, GB. | Pharmaceuticals: Major | Corporate Officer/Principal | |
The University of Liverpool
 The University of Liverpool Other Consumer ServicesConsumer Services The University of Liverpool operates as a university. It offers post graduate research, foundation courses, continuing and professional development, online study, and doctoral college. The company was founded in 1881 and is headquartered in Liverpool, the United Kingdom. | College/University | Undergraduate Degree | |
| University of Kent | College/University | Undergraduate Degree | |
Balter Medical AS
 Balter Medical AS Medical SpecialtiesHealth Technology Balter Medical AS engages in the development and commercialization of biomedical technology. Its product assists healthcare professionals in diagnosing patients with Melanoma. The company was founded by Jakob Johan Stamnes and Knut Stamnes on December 13, 2000 and is headquartered in Bergen, Norway. | Medical Specialties | Director/Board Member | |
| ARCTICZYMES TECHNOLOGIES ASA | Medical Specialties | Director/Board Member | |
| IRLAB THERAPEUTICS AB | Pharmaceuticals: Major | Chief Executive Officer | |
Royal Pharmaceutical Society of Great Britain
 Royal Pharmaceutical Society of Great Britain Miscellaneous Commercial ServicesCommercial Services The Royal Pharmaceutical Society of Great Britain provides expertise and support to its member pharmacists. The private company is based in Great Britain. Alex MacKinnon has been the CEO of the British company since 2010. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Norwegian University of Science & Technology | College/University | Graduate Degree | |
| London Business School | College/University | Masters Business Admin | |
Kantega AS
 Kantega AS Miscellaneous Commercial ServicesCommercial Services Kantega AS provides IT consulting services. It offers design, development, and the integration of applications for companies that require out sourcing services, as well as consultation and maintenance. The company was founded in 2003 and is headquartered in Oslo, Norway. | Miscellaneous Commercial Services | President | |
Boostcom Group AS
 Boostcom Group AS Packaged SoftwareTechnology Services Boostcom Group AS operates databases and offers short messaging system. The company was founded by Øystein Robertsen Skiri on June 30, 2000 and is headquartered in Trondheim, Norway. | Packaged Software | Director/Board Member | |
Uni Targeting Research AS
 Uni Targeting Research AS BiotechnologyHealth Technology Uni Targeting Research AS is a holding company that provides the biopharmaceutical industry with tools and services for mammalian cell-line based development procedures and production processes. It offers upstream solutions to reduce complementary deoxyribonucleic acid and mammalian cell-line based timelines and increase protein production yields. Its technology enables both enhanced synthesis/secretion of naturally secreted proteins, and secretion of intracellular proteins. Its services include vector improvement, tailor-made vectors, and tool proteins. The company was founded by Ian Fraser Pryme, John E. Hesketh, Albert Tauler, and Beate Stern in 2001 and is headquartered in Bergen, Norway. | Biotechnology | Chairman | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
CellCentric Ltd.
 CellCentric Ltd. Pharmaceuticals: MajorHealth Technology CellCentric Ltd. develops and commercializes small molecule inhibitors for cancer. Its active programs include inhibitors to histone methyltransferases, histone demethylases and epigenetic enzymes that act via ubiquitin. The company was founded by Alun Huw Jones, Catherine Denise Prescott, Azim Surani and William Henry Lewarne West in May 2004 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Bio-Me AS
 Bio-Me AS BiotechnologyHealth Technology Bio-Me AS operates as a boi-tech firm. It researches and develops patented technologies and new approaches in bacteria analysis. The company is headquartered in Oslo, Norway. | Biotechnology | Director/Board Member | |
Copenhagen Capacity
 Copenhagen Capacity Financial ConglomeratesFinance Copenhagen Capacity provides investment promotion and economic development services. The private company is based in Copenhagen, Denmark. Asbjørn Overgaard Christiansen has been the CEO of the Danish company since 2020. | Financial Conglomerates | Director/Board Member | |
Genzyme Europe BV
 Genzyme Europe BV Pharmaceuticals: MajorHealth Technology Part of Sanofi, Genzyme Europe BV is a Dutch company that develops and manufactures pharmaceutical and biotherapeutic products. The company is based in Amsterdam, Netherlands. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| WEIFA ASA | Pharmaceuticals: Major | Director/Board Member | |
| CALLIDITAS THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member |
Estadísticas
Internacional
| Noruega | 22 |
| Reino Unido | 19 |
| Estados Unidos | 5 |
| Dinamarca | 3 |
| Suecia | 3 |
Sectorial
| Health Technology | 22 |
| Consumer Services | 12 |
| Commercial Services | 8 |
| Finance | 4 |
| Distribution Services | 4 |
Operativa
| Director/Board Member | 122 |
| Corporate Officer/Principal | 75 |
| Chairman | 37 |
| Independent Dir/Board Member | 28 |
| Chief Tech/Sci/R&D Officer | 26 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Susan Foden | 32 |
| François Thomas | 25 |
| Sveinung Hole | 25 |
| Martin Olin | 25 |
| Hilde Furberg | 21 |
| Jon-Øyvind Eriksen | 16 |
| Stein Holst Annexstad | 15 |
| Richard Stuart Godfrey | 15 |
| Gayle Mills | 12 |
| Anders Lennart Tullgren | 12 |
| Kari Grønås | 12 |
| Dominic Smethurst | 11 |
| Debra Stephanie Barker | 11 |
| Sally Bennett | 10 |
| Alan Barge | 10 |
- Bolsa de valores
- Insiders
- Rune Skeie
- Conexiones Empresas
